| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| parp inhibitor drugs | 1.75 | 0.9 | 9394 | 73 | 20 |
| parp | 1.55 | 0.1 | 3024 | 94 | 4 |
| inhibitor | 1.22 | 1 | 7149 | 19 | 9 |
| drugs | 0.45 | 0.7 | 4118 | 19 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| parp inhibitor drugs | 1.26 | 0.9 | 8619 | 21 |
| parp inhibitor drugs ovarian cancer | 1.19 | 0.3 | 7699 | 95 |
| parp inhibitor drugs side effects | 0.51 | 0.3 | 8688 | 61 |
| parp inhibitor drugs for prostate cancer | 1.86 | 0.3 | 2897 | 97 |
| parp inhibitor drugs under clinical trials | 1.1 | 0.9 | 3482 | 32 |
| list of parp inhibitor drugs | 1.81 | 0.6 | 3877 | 30 |
| what are parp inhibitor drugs | 1.87 | 0.1 | 9817 | 49 |
| what is a parp inhibitor drug | 0.35 | 0.7 | 4641 | 84 |
| parp inhibitor clinical trial drugs | 1.08 | 0.3 | 3627 | 55 |
| parp inhibitor maintenance ovarian cancer | 1.34 | 0.8 | 2350 | 33 |
| fda approval parp inhibitor ovarian cancer | 0.67 | 0.1 | 1374 | 11 |
| parp inhibitor ovarian cancer 2020 | 0.34 | 0.7 | 5656 | 97 |
| parp inhibitor resistance ovarian cancer | 0.24 | 0.5 | 7161 | 52 |
| parp inhibitor ovarian cancer niraparib | 1.3 | 0.9 | 8170 | 86 |
| parp for ovarian cancer | 0.98 | 0.1 | 3901 | 76 |
| parp inhibitor for breast cancer | 0.95 | 0.2 | 4502 | 67 |
